TriSalus Life Sciences (NASDAQ:TLSI) Given New $12.00 Price Target at Canaccord Genuity Group

TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) had its price objective upped by investment analysts at Canaccord Genuity Group from $11.00 to $12.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 64.27% from the company’s [...]

Read Full Article →